Researchers for the massive DAPT study find that drug-eluting stents may be safer than bare-metal stents, calling into question the value of Boston Scientific's next-gen Synergy stent.
Researchers for the massive Dual Anti-platelet Therapy Study found that patients receiving drug-eluting stents had a lower rate of stent thrombosis and other major cardiovascular events than those treated with bare-metal stents, undermining the common perception that bare-metal stents are safer.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/11YW3jW
Cap comentari:
Publica un comentari a l'entrada